medline.ch Onkologie Gynäkologische Tumoren

	Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study. Breast Cancer Res Treat Tian Z, Li H, Deng Y, Yao H, Wang Y, Jin L, Deng H, Chen N, Liu J. PMID: 42671642 [PubMed - indexed for MEDLINE]
	Feasibility of EHR-Based Prescreening for an Adjuvant Breast Cancer Trial in a Safety-Net Health System. Oncologist Alkhafaji H, Reynolds LCK, Howell M, Henderson JD, Preece D, Teigen KJ, Gerber DE, Narra K. PMID: 42671355 [PubMed - as supplied by publisher]
	A Habitat Imaging-Based Radiomics and Deep Learning Fusion for Preoperative Prediction of Lymphovascular Invasion in Invasive Breast Cancer: A Multicenter Study. Balkan Med J Zhong L, Wang K, Xie J, Shi L, Gu L, Zheng Y, Yi X. PMID: 42671326 [PubMed - as supplied by publisher]
	The performance and role of BI-RADS classification in predicting malignancy in non-palpable breast lesions. Malays J Pathol Abu N, Lai SK, Hussin H, Shamsudin NH. PMID: 42671236 [PubMed - indexed for MEDLINE]
	HER2 ultralow in metastatic breast cancer: Diagnostic boundaries in the era of antibody-drug conjugates. Malays J Pathol Ch'ng ES. PMID: 42671229 [PubMed - indexed for MEDLINE]
	The KPROCS Study: A Real-World and Research Resource to Investigate Multilevel Determinants of Ovarian Cancer Treatment and Survival. Cancer Epidemiol Biomarkers Prev Bandera EV, Doherty JA, Lee VS, Collin LJ, Kavecansky J, Khosrow-Khavar F, Li J, Moy LM, Chirikova E, Inamdar PP, Shariff-Marco S, Grieshober L, Köbel M, Gomez SL, Kushi LH. PMID: 42671158 [PubMed - as supplied by publisher]
	Outcome of an intervention based on adjusting the threshold for hyponatremia in patients undergoing myomectomy: A case control study. Afr J Reprod Health Yang Z, Wang L, Wang Y, Liu Z, Ai H, Pei W, Xu S, Lu L, Luo J. PMID: 42670791 [PubMed - indexed for MEDLINE]
	Developments in human papillomavirus vaccines, schedules, and implementation strategies. J Natl Cancer Inst Monogr Bruni L, Brotons M, Alvarez J, Roden RBS. PMID: 42670627 [PubMed - indexed for MEDLINE]
	Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study. J Natl Cancer Inst Monogr Simms KT, de Bondt D, Killen J, Sy S, Naslazi E, Regan MC, Burger EA, Kim JJ, Smith MA, de Kok IMCM, Canfell K. PMID: 42670626 [PubMed - indexed for MEDLINE]
	From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening. J Natl Cancer Inst Monogr Adsul P, Adcock R. PMID: 42670625 [PubMed - indexed for MEDLINE]
	Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries. J Natl Cancer Inst Monogr Almonte M, Tejada RA, Calderón A, Baena A. PMID: 42670624 [PubMed - indexed for MEDLINE]
	Deintensification of cervical cancer screening in the era of high human papillomavirus-vaccination coverage. J Natl Cancer Inst Monogr Bonde J, Castle PE. PMID: 42670623 [PubMed - indexed for MEDLINE]
	How to evaluate and select cervical screening and triage tests in vaccinated populations. J Natl Cancer Inst Monogr Wentzensen N, Arbyn M, Poljak M. PMID: 42670622 [PubMed - indexed for MEDLINE]
	How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers. J Natl Cancer Inst Monogr Basu P, Lucas E, Elfström KM. PMID: 42670621 [PubMed - indexed for MEDLINE]
	Effective communications to support risk-adapted cervical screening in human papillomavirus-vaccinated women: lessons learned and ways forward. J Natl Cancer Inst Monogr Waller J, Marlow L. PMID: 42670620 [PubMed - indexed for MEDLINE]
	The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs. J Natl Cancer Inst Monogr El-Zein M, Franco EL. PMID: 42670619 [PubMed - indexed for MEDLINE]
	Evidence for type replacement as a consequence of vaccination and implications for cervical screening. J Natl Cancer Inst Monogr Gray P, Louvanto K. PMID: 42670618 [PubMed - indexed for MEDLINE]
	Study on the Pathway Mechanism of Social Support and Quality of Life Between Self-Disclosure and Stigma Among Breast Cancer Patients During Recovery. Breast J Lin S, Zhang B, Yu S, Wang C, Zheng J, Cao Z, Xu H, Fan G. PMID: 42670220 [PubMed - indexed for MEDLINE]
	Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple-Negative Breast Tumours. Anal Cell Pathol (Amst) Choque J, Aguilar A, Enciso-Benavides J, Rojas-Moran N, Enciso N, Altamirano CC, Castillo M, Alfaro L, Enciso J. PMID: 42670211 [PubMed - indexed for MEDLINE]
	Meeting Highlights: The 11th Korean Breast Cancer Society Consensus Conference on Axillary Management in Early Breast Cancer. J Breast Cancer Bae SJ, Lee JH, Lee SA, Won HS, Kim HJ, Chae H, Shin K, Hong JH, Cha YJ, Ahn HK, Han A, Han SA, Korean Breast Cancer Treatment Consensus Conference Panelists. PMID: 42669950 [PubMed]

Artikel 1 - 20 / 334431

Seite 1 von 16722

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung